甲型肝炎 A 型肝炎

Same author

Review article: the efficacy and safety of sofosbuvir, a novel, oral nucleotide NS5B polymerase inhibitor, in the treatment of chronic hepatitis C virus infection.

Alimentary pharmacology & therapeutics·2014

Same author

Review article: vaccination and viral hepatitis - current status and future prospects.

Alimentary pharmacology & therapeutics·2007

Same author

Prevention of hepatitis C virus infection.

Clinics in liver disease·2004

Same author

Terbinafine-induced hepatitis and pancytopenia.

Digestive diseases and sciences·2001

Same author

Risks associated with hepatitis A and hepatitis B in patients with hepatitis C.

Journal of clinical gastroenterology·2001

Same author

Hepatitis vaccines.

Infectious disease clinics of North America·2001

Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026

Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026

Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026

Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026

Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026

Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026

相关实验视频

甲型肝炎 A 型肝炎

相关概念视频

Review article: the efficacy and safety of sofosbuvir, a novel, oral nucleotide NS5B polymerase inhibitor, in the treatment of chronic hepatitis C virus infection.

Review article: vaccination and viral hepatitis - current status and future prospects.

Prevention of hepatitis C virus infection.

Terbinafine-induced hepatitis and pancytopenia.

Risks associated with hepatitis A and hepatitis B in patients with hepatitis C.

Hepatitis vaccines.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

相关实验视频

甲型肝炎 A 型肝炎

相关概念视频

相关文章

Review article: the efficacy and safety of sofosbuvir, a novel, oral nucleotide NS5B polymerase inhibitor, in the treatment of chronic hepatitis C virus infection.

Review article: vaccination and viral hepatitis - current status and future prospects.

Prevention of hepatitis C virus infection.

Terbinafine-induced hepatitis and pancytopenia.

Risks associated with hepatitis A and hepatitis B in patients with hepatitis C.

Hepatitis vaccines.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.